{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:27:35Z","timestamp":1761863255253},"reference-count":18,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T00:00:00Z","timestamp":1386892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T00:00:00Z","timestamp":1386892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Novo Nordisk A\/S","award":["NCT00825643","NCT00740519"],"award-info":[{"award-number":["NCT00825643","NCT00740519"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1111\/jcpt.12116","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T10:34:38Z","timestamp":1386930878000},"page":"136-143","source":"Crossref","is-referenced-by-count":4,"title":["Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes"],"prefix":"10.1155","volume":"39","author":[{"given":"J.","family":"Vora","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology; Royal Liverpool University Hospital; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Caputo","sequence":"additional","affiliation":[{"name":"Servizio di Diabetologia; Policlinico Gemelli; Universita`Cattolica; Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Damci","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism; Istanbul University; Cerrahpasa Medical School; Istanbul Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Orozco-Beltran","sequence":"additional","affiliation":[{"name":"Cathedra of Family Medicine; Department of Medicine; University Miguel Hernandez; Alicante Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology; Chinese PLA General Hospital; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Svendsen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Epidemiology; Novo Nordisk A\/S; S\u00f8borg Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"S\u00f8lje","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs; Novo Nordisk A\/S; S\u00f8borg Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Khunti","sequence":"additional","affiliation":[{"name":"Diabetes Research Unit; University of Leicester; Leicester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The SOLVE study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,12,13]]},"reference":[{"key":"10.1111\/jcpt.12116-BIB0001|jcpt12116-cit-0001","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12116-BIB0002|jcpt12116-cit-0002","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1111\/jcpt.12116-BIB0003|jcpt12116-cit-0003","first-page":"S27","article-title":"Implications of the United Kingdom prospective diabetes study","volume":"23","author":"American Diabetes Association","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1111\/jcpt.12116-BIB0004|jcpt12116-cit-0004","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/14740338.2010.492777","article-title":"Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients","volume":"9","author":"Holstein","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/jcpt.12116-BIB0005|jcpt12116-cit-0005","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2011-1074","article-title":"Weight beneficial treatments for type 2 diabetes","volume":"96","author":"Meneghini","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/jcpt.12116-BIB0006|jcpt12116-cit-0006","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/SMJ.0b013e3181c35776","article-title":"The continuation of oral medications with the initiation of insulin therapy in type 2 diabetes: a review of the evidence","volume":"103","author":"McFarland","year":"2010","journal-title":"South Med J"},{"key":"10.1111\/jcpt.12116-BIB0007|jcpt12116-cit-0007","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.diabet.2012.08.002","article-title":"Incretin-based therapy in combination with basal insulin: A promising tactic for the treatment of type 2 diabetes","volume":"39","author":"Vora","year":"2013","journal-title":"Diabetes Metab"},{"key":"10.1111\/jcpt.12116-BIB0008|jcpt12116-cit-0008","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1463-1326.2012.01602.x","article-title":"Study of once-daily levemir (SOLVE): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice","volume":"14","author":"Khunti","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/jcpt.12116-BIB0009|jcpt12116-cit-0009","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1463-1326.2012.01665.x","article-title":"The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries","volume":"14","author":"Khunti","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/jcpt.12116-BIB0010|jcpt12116-cit-0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/EJE-11-0022","article-title":"Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues","volume":"166","author":"Vaag","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/jcpt.12116-BIB0011|jcpt12116-cit-0011","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1463-1326.2010.01258.x","article-title":"Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes","volume":"12","author":"Swinnen","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/jcpt.12116-BIB0012|jcpt12116-cit-0012","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc08-1171","article-title":"Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis","volume":"31","author":"Bodmer","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1111\/jcpt.12116-BIB0013|jcpt12116-cit-0013","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc06-1789","article-title":"A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin","volume":"30","author":"Gangji","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/jcpt.12116-BIB0014|jcpt12116-cit-0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2003-44287","article-title":"Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes","volume":"111","author":"Holstein","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/jcpt.12116-BIB0015|jcpt12116-cit-0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1463-1326.2009.01060.x","article-title":"Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study","volume":"11","author":"Blonde","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/jcpt.12116-BIB0016|jcpt12116-cit-0016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.diabres.2010.10.002","article-title":"Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain","volume":"91","author":"Conthe","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/jcpt.12116-BIB0017|jcpt12116-cit-0017","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.clinthera.2006.10.020","article-title":"Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes","volume":"28","author":"Philis-Tsimikas","year":"2006","journal-title":"Clin Ther"},{"key":"10.1111\/jcpt.12116-BIB0018|jcpt12116-cit-0018","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00125-005-0132-0","article-title":"Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study","volume":"49","author":"Yki-Jarvinen","year":"2006","journal-title":"Diabetologia"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12116","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12116\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:11Z","timestamp":1671818711000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,13]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12116","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"type":"print","value":"0269-4727"}],"subject":[],"published":{"date-parts":[[2013,12,13]]}}}